Article
Mutational activation of the MAP3K8 protooncogene in lung cancer.
Genes, chromosomes & cancer - 1 Oct 2004
Clark Adam Michael, Reynolds Steven H, Anderson Marshall, Wiest Jonathan S
Abstract excerpt
The MAP3K8 protooncogene (Cot/Tpl-2) activates the MAP kinase, SAP kinase, and NF-kappaB signaling pathways. MAP3K8 mutations occur in the rat homologue, but activating mutations have yet to be identified in primary human tumors. We have identified MAP3K8 as a transforming gene from a human lung adenocarcinoma and characterized a 3' end mutation in the cDNA. In addition, we confirmed that the mutation occurs in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
